Defense Biotechnology Strategy Act
Key claim: A House bill to establish a defense biotechnology strategy has been introduced and sent to the Armed Services and Foreign Affairs committees for consideration.
Abstract
(HR6009 · 119th Congress) Latest action (2025-11-10): Referred to the Committee on Armed Services, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Why this matters
A statutory defense biotechnology strategy would formalize DoD priorities for biotech R&D and could shape how defense agencies fund, partner with, and set security expectations for university and industry biotech researchers. At the introduction stage the practical effect is prospective — committee markup in Armed Services and Foreign Affairs will determine whether the strategy carries funding authorizations or research-security provisions that reach the broader science workforce.